Genome editing and human rights:Implications of the UNGPs  

作　　者：Leifan Wang Xiaohui Liang Weiwen Zhang 

机构地区：[1]Tianjin University Law School,Tianjin 300072,China [2]Center for Biosafety Research and Strategy,Tianjin University,Tianjin 300072,China [3]China National Textile and Apparel Council,Beijing 100027,China [4]Peking University Law School,Beijing 100871,China [5]School of Chemical Engineering and Technology,Tianjin University,Tianjin 300072,China [6]Frontier Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering(MOE),School of Chemical Engineering and Technology,Tianjin University,Tianjin 300072,China

出　　处：《Biosafety and Health》2022年第6期386-391,共6页生物安全与健康（英文）

基　　金：supported by grants from the National Key Research and Development Program of China(Grant nos.2019YFA0904600 and 2020YFA0908600).

摘　　要：How to address the impact of genome editing on human rights is a global challenge.The World Health Organization(WHO)recently developed a governance framework for human genome editing to provide global recommendations for establishing appropriate governance mechanisms for human genome editing.This article suggests that a human rights-respecting approach should be explicitly recognized in the framework and other relevant endeavors.Such recognition has significant implications not only on clarifying the duty of States but also on the responsibility of non-State actors,particularly biotech enterprises,to orient this technology towards respect for human rights.To implement this approach,the United Nations Guiding Principles on Business and Human Rights(UNGPs)provide helpful guidance for States,biotech enterprises,and other stakeholders to raise awareness and enhance responsible practices in the field.

关 键 词：Genome editing Human rights UNGPs Biotech enterprises 

分 类 号：R-05[医药卫生] D815.7[政治法律—国际关系]